Verification register Bio, Health & Neuro
Current reading
The readiness gap, in one scan
AI-assisted assembly · derived results
- Claimed
- 70
- Reported
- 68
- Verified
- 63
- Gap
- +7
Public ambition and stated capability
Observed practitioner reporting
Independently supported evidence
Claimed minus verified
Evidence strength Growing
Decision
What the current evidence supports
Human editorial judgment · 2026-06-28
Proceed with caution
- Why
- Open weights plus credible million-scale, picomolar-affinity validation and named adopters (Novo Nordisk, Viva Biotech, Manifold) make it a serious, adoptable design tool, but inflated speed claims, uneven per-target hit rates, and heavy GPU/assay dependencies warrant a measured in-house pilot first.
- Next
- Stand up the open weights on an A100/H100 via BioNeMo and benchmark on an internal protein target set, measuring real per-target hit rate and the actual (~4.5x) RFdiffusion speedup before any campaign-scale commitment.
Constraints
Blockers
No named blocker is present in the current public projection.
Evidence summary
Derived counts
AI-assisted assembly
- Total
- 6
- Tier 1
- 0
- Tier 2
- 2
- Tier 3
- 4
- Supports
- 3
- Contradicts
- 1
- Context
- 2
- Latest observed
- 2026-03-16
Counts and dates only. Raw signals, private excerpts, trust records, and internal corpus material are not published here.
Publication record
Revisions
Initial public reading
This is the initial public reading. No earlier readiness change is recorded.